|
|
Office Locations:
|
433 Temple Street
New Haven, CT 06511
Phone: 203-436-8096
Fax: 203-436-8086
| |
|
|
|
|
|
|
Energy & Clean Tech
Life Sciences & Healthcare
Medical Device
Software & Internet
|
|
|
|
The Yale University Office of Cooperative Research (OCR) was founded in 1982 and charged with extending and expanding Yale University's interaction with the private sector. The duties of the OCR include oversight for patenting and licensing activities, university inventions, and contractual relationships between faculty and industry. OCR staff work with Yale researchers to identify inventions that may ultimately become commercial products and services useful to the public. OCR staff also engage in industrial partnerships to license Yale inventions. The Office of Cooperative Research helps launch several new ventures every year. OCR is currently investing through the Blavatnik Fund. The Blavatnik Fund for Innovation bridges the gap between innovative, early-stage life science research and successful development of high-impact biomedical products. Pilot grants are eligible for up to $100,000 and development grants are eligible for up to $300,000. OCR's venture capital investment is $3.7 billion from 2015 to 2021.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
